Morales, Anecita .

HRN: 29-11-72  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/08/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/08/2026
06/15/2026
IV
600mg
Q6
Cellulitis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: